N/A
Manufactured by Blaine Labs Inc.
121 FDA adverse event reports analyzed
Last updated: 2026-04-15
UNDECYLENIC ACID is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Blaine Labs Inc.. The most commonly reported adverse reactions for UNDECYLENIC ACID include NAUSEA, SOMNOLENCE, TREATMENT FAILURE, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS, ASTHENIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for UNDECYLENIC ACID.
Out of 37 classified reports for UNDECYLENIC ACID:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 121 FDA FAERS reports that mention UNDECYLENIC ACID. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include NAUSEA, SOMNOLENCE, TREATMENT FAILURE, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS, ASTHENIA, CONFUSIONAL STATE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Blaine Labs Inc. in connection with UNDECYLENIC ACID. Always verify the specific product and NDC with your pharmacist.